Artisan Partners’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-706,140
Closed -$19.3M 327
2022
Q2
$19.3M Sell
706,140
-121,955
-15% -$3.61M 0.03% 254
2022
Q1
$31.2M Buy
828,095
+4,693
+0.6% +$208K 0.04% 262
2021
Q4
$51.1M Buy
823,402
+74,686
+10% +$5.66M 0.06% 246
2021
Q3
$64.1M Sell
748,716
-23,193
-3% -$1.46M 0.08% 225
2021
Q2
$47.8M Sell
771,909
-464
-0.1% -$23.6K 0.06% 243
2021
Q1
$37.7M Buy
+772,373
New +$37.3M 0.05% 276

Other funds holding OPRX

Artisan Partners's OPRX Position: Q3 2022 in Review

Artisan Partners sold out of OptimizeRx (OPRX) in Q3 2022, closing a stake of 706,140 shares — an estimated $19.3M sold.

Artisan Partners first reported a position in OPRX in Q1 2021 and held it in 6 quarters. The position peaked at $64.1M in Q3 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q3 2022.

  • Artisan Partners reported no remaining OptimizeRx position as of Q3 2022 after selling out during the quarter.
  • Artisan Partners sold 706,140 OptimizeRx shares in Q3 2022, an estimated $19.3M.
  • Artisan Partners first reported a position in OptimizeRx in Q1 2021 and held it in 6 quarters.
  • Artisan Partners's OptimizeRx position peaked at $64.1M in Q3 2021.
  • 128 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2022.

Based on Artisan Partners's 13F filing for Q3 2022, filed 10 Nov 2022.